A phase 2 study of Anlotinib Hydrochloride combined with temozolomide in the treatment of recurrent high grade glioma
Latest Information Update: 17 Jan 2025
Price :
$35 *
At a glance
- Drugs Catequentinib (Primary) ; Temozolomide
- Indications Glioma
- Focus Therapeutic Use
- 17 Jan 2025 New trial record